News & Articles
Chemical laboratory changes for Covid-19 patients
New formula for molecular probes
The new formula incorporates genetic manipulation of the optical refractive index of live cell components leading to their use as molecular probes demonstrated for the first time
Key discovery in psoriatic arthritis points way for developing targeted treatments
A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients
Study shows early treatment for leg ulcers leads to better outcomes for patients
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
Coronavirus (COVID-19) update: FDA authorizes first point-of-care antibody test for COVID-19
The Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by certain labs in July 2020
Abbott receives CE mark for MitraClip heart valve repair device to treat mitral regurgitation
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
QIAGEN acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems
Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.
Promega developing OncoMate MSI Assay as companion diagnostic for endometrial cancer drug candidate
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
DiaSorin's Simplexa COVID-19 direct molecular test CE marked for saliva specimens
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
Arctoris and Syntekabio form research partnership
Research shows that stroke scans could reveal COVID-19 infection
Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed
AstraZeneca acquires oral PCSK9 inhibitor program from Dogma Therapeutics
AstraZeneca anticipates entering clinical development in 2021
Beckman Coulter praised by Frost & Sullivan for accelerating sepsis detection with the DxH 690T
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
Rapid 90-minute COVID-19 test shown to be highly accurate
In the research, the high-speed tests, which do not require a laboratory and can be performed in cartridges smaller than a mobile phone
Ocean acidification puts deep-sea coral reefs at risk of collapse
Deep-sea coral reefs face challenges as changes to ocean chemistry triggered by climate change may cause their foundations to become brittle
The road to greener hydrogen
Hydrogen now isn’t everything that hydrogen could be, writes Mats W. Lundberg, sustainable business manager at Sandvik Materials Technology